Assyro AI

Orange Book product · Brand (NDA)

FYCOMPA

PERAMPANEL

Brand (NDA)NDA 202834TE ABRX CATALYST PHARMS

At a glance

Oct 22, 2012

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 22, 2012

    13 yr 10 mo ago

  2. Today

  3. Patent 8772497 expires

    Listed drug substance patent expiration.

    Jul 01, 2026

    in 12 d

Pharmaceutical detail

Active ingredient

PERAMPANEL

Strength

2MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 202834

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8772497Jul 01, 2026in 12 d
Substance
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.